5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.49▼ | 1.50▼ | 1.50▼ | 1.53▼ | 1.35▲ |
MA10 | 1.46▲ | 1.45▲ | 1.45▲ | 1.47▼ | 1.50▼ |
MA20 | 1.49▼ | 1.49▼ | 1.49▼ | 1.38▲ | 2.00▼ |
MA50 | 1.39▲ | 1.44▲ | 1.45▲ | 1.58▼ | 2.92▼ |
MA100 | 1.77▼ | 1.98▼ | 2.03▼ | 2.10▼ | 7.22▼ |
MA200 | 2.50▼ | 2.71▼ | 2.75▼ | 2.85▼ | 21.41▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | 0.013▲ | 0.015▲ | 0.034▲ | 0.019▲ |
RSI | 51.168▲ | 51.404▲ | 51.144▲ | 49.741▼ | 33.397▼ |
STOCH | 71.876 | 77.469 | 77.469 | 51.691 | 21.317 |
WILL %R | -29.310 | -29.310 | -29.310 | -58.429 | -71.927 |
CCI | 45.431 | 46.125 | 46.125 | 6.340 | -48.893 |
Thursday, May 16, 2024 01:01 AM
BOSTON and LONDON, May 16, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, ...
|
Monday, May 13, 2024 04:00 PM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
|
Sunday, May 12, 2024 05:00 PM
Are you looking to diversify your portfolio with promising penny stocks? Take a look at these NYSE penny stocks that are going strong in the market. Generally speaking, penny stocks are small ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/05/24 | 1.455 | 1.50 | 1.455 | 1.46 | 9,076 |
14/05/24 | 1.55 | 1.55 | 1.4101 | 1.50 | 16,426 |
13/05/24 | 1.53 | 1.53 | 1.48 | 1.48 | 3,836 |
10/05/24 | 1.55 | 1.65 | 1.55 | 1.60 | 19,063 |
09/05/24 | 1.52 | 1.75 | 1.52 | 1.635 | 30,367 |
08/05/24 | 1.50 | 1.50 | 1.32 | 1.45 | 11,663 |
07/05/24 | 1.402 | 1.49 | 1.35 | 1.45 | 12,419 |
06/05/24 | 1.40 | 1.40 | 1.1701 | 1.34 | 16,327 |
03/05/24 | 1.579 | 1.59 | 1.33 | 1.36 | 20,772 |
02/05/24 | 1.69 | 1.8676 | 1.4283 | 1.47 | 38,277 |
|
|
||||
|
|
||||
|
|